Ligand profile
CHEMBL3319272
Bioactivity hit from ChEMBL on a similar protein.
Bound to: VK055_0782 — FAD binding domain protein
Identifiers
Database identifiers and provenance.
- Ligand ID
CHEMBL3319272- UniProt (similar protein)
P19643- pchembl
- 8.430 (~3.7 nM)
- Target protein
- VK055_0782
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 41.0
- −1 ≤ LogP ≤ 5 4.62
- MW ≤ 500 Da 290.2
- LogP ≤ 5 4.62
- H-bond donors ≤ 5 1
- H-bond acceptors ≤ 10 2
- Rotatable bonds ≤ 10 2
- TPSA ≤ 140 Ų 41.0
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
Clc1ccc(/N=C/c2ccc3[nH]ncc3c2)cc1ClClc1ccc(/N=C/c2ccc3[nH]ncc3c2)cc1Cl
InChI=1S/C14H9Cl2N3/c15-12-3-2-11(6-13(12)16)17-7-9-1-4-14-10(5-9)8-18-19-14/h1-8H,(H,18,19)/b17-7+InChI=1S/C14H9Cl2N3/c15-12-3-2-11(6-13(12)16)17-7-9-1-4-14-10(5-9)8-18-19-14/h1-8H,(H,18,19)/b17-7+
ODHPFVFFVLSYBF-REZTVBANSA-NODHPFVFFVLSYBF-REZTVBANSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- ChEMBL
- Binding sites
- PF01593
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ChEMBL ChEMBL compound CHEMBL3319272 →
- UniProt UniProt P19643 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “CHEMBL3319272”) →
Other ligands for this protein
Quick navigation to other ligands bound to VK055_0782.
PDB 4
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 99
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).